Rexahn Pharmaceuticals Inc.


Rexahn Pharmaceuticals, Inc. (RNN): Chang Ahn Stepping Down

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) announced its founder, Chang Ahn, Ph.

Rexahn Pharmaceuticals, Inc. (RNN) Announces 2Q:17 Financial and Operational Results

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) announced financial results for the second quarter ended June 30, 2017 and provided an update on the Company’s clinical …

Rexahn Pharmaceuticals, Inc. (RNN) Tumbles on Share Dilution

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) announced it has entered into definitive agreements with institutional investors to purchase approximately 3.

Rodman & Renshaw Encouraged on Rexahn Pharmaceuticals, Inc. (RNN) Following ASCO Update

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) offered a key glimpse into its advanced muscle invasive bladder cancer (MIBC) Phase 2a trial  at the American Society …

Rexahn Pharmaceuticals, Inc. (RNN) Challenged with Financing Overhang; FBR Slashed Price Target

FBR analyst Vernon Bernardino, one of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) biggest bulls, is slashing the price target for the drug maker to $14.

Rexahn Pharmaceuticals, Inc. (RNN) Announces Q1:17 Results

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) announced financial results for the first quarter ended March 31, 2017 and provided an update on the Company’s clinical …